Reproterol

From Infogalactic: the planetary knowledge core
Jump to: navigation, search
Reproterol
Reproterol.png
Systematic (IUPAC) name
(RS)-7-(3-{[2-(3,5-dihydroxyphenyl)-2-hydroxyethyl]amino}propyl)-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione
Clinical data
AHFS/Drugs.com International Drug Names
Identifiers
CAS Number 54063-54-6 YesY
ATC code R03AC15 (WHO)
PubChem CID: 25654
ChemSpider 23898 N
UNII 11941YC6RN YesY
KEGG D08474 YesY
ChEMBL CHEMBL1095607 N
Chemical data
Formula C18H23N5O5
Molecular mass 389.406 g/mol
  • CN1C2=C(C(=O)N(C1=O)C)N(C=N2)CCCNCC(C3=CC(=CC(=C3)O)O)O
  • InChI=1S/C18H23N5O5/c1-21-16-15(17(27)22(2)18(21)28)23(10-20-16)5-3-4-19-9-14(26)11-6-12(24)8-13(25)7-11/h6-8,10,14,19,24-26H,3-5,9H2,1-2H3 N
  • Key:WVLAAKXASPCBGT-UHFFFAOYSA-N N
 NYesY (what is this?)  (verify)

Reproterol (INN) is a β2-adrenergic receptor agonist used in the treatment of asthma.[1]

References

  1. ↑ Virchow JC Jr. Reproterol: beta-2-agonist, theophylline, or both? Respiration. 1999;66(3):210-1. PMID 10364735

<templatestyles src="Asbox/styles.css"></templatestyles>

Stub icon

This drug article relating to the respiratory system is a stub. You can help Wikipedia by expanding it.
Retrieved from "https://infogalactic.com/w/index.php?title=Reproterol&oldid=4911297"